McKesson(US:MCK) ZACKSยท2024-09-13 22:56Company Performance - McKesson's stock closed at $518.81, reflecting a +1.49% change from the previous trading day, outperforming the S&P 500's daily gain of 0.54% [1] - Over the past month, McKesson shares have decreased by 6.28%, underperforming compared to the Medical sector's gain of 4.37% and the S&P 500's gain of 4.86% [1] - The upcoming earnings report is expected to show an EPS of $7.20, which is a 15.57% increase from the same quarter last year, with projected net sales of $89.57 billion, up 16% year-over-year [1] Annual Estimates - For the annual period, the Zacks Consensus Estimates predict earnings of $32.11 per share and revenue of $353.29 billion, representing increases of +17.02% and +14.35% respectively from the previous year [2] - Recent revisions to analyst forecasts for McKesson are crucial as they indicate changing business trends, with upward revisions reflecting analysts' positive outlook on the company's operations [2] Valuation Metrics - McKesson has a Zacks Rank of 3 (Hold), with the Zacks Consensus EPS estimate increasing by 2.25% over the last 30 days [3] - The company is currently trading at a Forward P/E ratio of 15.92, which is lower than the industry average Forward P/E of 18.64 [3] - McKesson's PEG ratio stands at 1.18, compared to the Medical - Dental Supplies industry's average PEG ratio of 1.91 [3] Industry Context - The Medical - Dental Supplies industry, part of the Medical sector, has a Zacks Industry Rank of 201, placing it in the bottom 21% of over 250 industries [4] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [4]